Pharmaceutical Strategy – Phase 2
Phase 2, announced October 20, 2009, focuses on generic drug prices and expanding the roles of pharmacists.
Phase 2 of the strategy includes:
- Reducing the price of generic drugs –
- Prices for new generic drugs will be reduced from 75% of a brand name drug price to 45%.
- Providing faster access to new, innovative drugs and reduce costs –
- Alberta will negotiate contracts, known as product listing agreements, with brand name drug manufacturers.
- Expanding the role of pharmacists to better meet the needs of patients –
- Government will work closely with Alberta pharmacists and pharmacies to have pharmacists spend more time using their knowledge and skill to counsel and advise patients.
- A comprehensive transition plan, which includes $5 million for rural and remote pharmacies and a transitional allowance for all pharmacies for 3 years –
- Developed to help support pharmacies as they shift their focus from dispensing prescription drugs to providing more professional services.
Read the fact sheets below for more details.
Fact sheets – Phase 2, updated January 28, 2010
News
- More health care options for Albertans with expanded role for pharmacists Feb. 13, 2012
- New drug program for seniors delayed NR: March 31, 2010
- Albertans to benefit from reduced prices for existing generic drugs NR: January 28, 2010
- Alberta to reduce drug costs and increase access to new drugs NR: October 20, 2009
- Proposed legislation provides more accessible drug coverage, improved drug review process NR: April 29, 2009
- Government improves seniors' drug plan NR: April 23, 2009
- Province introduces new pharmaceutical strategy to benefit Albertans NR: December 8, 2008
